|
32
|
133
|
7g1vA |
Crystal structure of human fabp4 in complex with 3-[(2-sulfanylphenyl)carbamoyl]bicyclo[2.2.1]heptane-2-carboxylic acid |
|
36
|
134
|
7g0aA |
Crystal structure of human fabp4 in complex with 5-(6-chloro-4-phenyl-2-piperidin-1-ylquinolin-3-yl)-3h-1,3,4-oxadiazol-2-one |
|
33
|
133
|
7fycA |
Crystal structure of human fabp4 in complex with (2r)-1-[(2-phenylphenyl)carbamoyl]pyrrolidine-2-carboxylic acid |
|
35
|
134
|
7fy0A |
Crystal structure of human fabp5 in complex with (2r)-1-[(3,5-dichloro-2-phenylphenyl)carbamoyl]pyrrolidine-2-carboxylic acid |
|
31
|
133
|
7fweA |
Crystal structure of human fabp4 in complex with 3-(4-chlorophenyl)sulfanylbutanoic acid |
|
32
|
135
|
7fzvA |
Crystal structure of human fabp4 in complex with 1-[(2,4-dichlorophenyl)methyl]-4-hydroxy-3-[(e)-3-phenylprop-2-enyl]pyridin-2-one |
|
31
|
134
|
7fz6A |
Crystal structure of human fabp4 in complex with rac-(1r,2s)-2-(phenoxymethyl)cyclohexane-1-carboxylic acid |
|
34
|
135
|
7fz0A |
Crystal structure of human fabp4 in complex with 2-tert-butyl-6-ethyl-4,5-diphenyl-3-(1h-tetrazol-5-yl)pyridine |
|
31
|
133
|
7fzkA |
Crystal structure of human fabp4 binding site mutated to that of fabp3 in complex with myristate |
|
32
|
131
|
7fytA |
Crystal structure of human fabp4 in complex with 5-[(3-chloro-2-methylphenoxy)methyl]-2-phenyl-4h-[1,2,4]triazolo[1,5-a]pyrimidin-7-one |
|
31
|
133
|
7fvyA |
Crystal structure of human fabp4 in complex with 2-[(3-chlorophenyl)methyl]-1,3-thiazole-4-carboxylic acid |
|
34
|
133
|
7fwrA |
Crystal structure of human fabp4 in complex with 3-[(3,4-dichlorophenyl)methylsulfanyl]-1,2,4-triazin-5-ol |
|
33
|
134
|
7fwaA |
Crystal structure of human fabp4 in complex with 5-[(4-chloroanilino)methyl]-2-phenyl-4h-[1,2,4]triazolo[1,5-a]pyrimidin-7-one |
|
31
|
133
|
7g1lA |
Crystal structure of human fabp4 in complex with 6-(1,3-benzodioxol-5-ylmethyl)-3-sulfanyl-1,2,4-triazin-5-ol |
|
33
|
134
|
7g17A |
Crystal structure of human fabp4 in complex with 2-(1h-indol-7-yloxymethyl)-1,3-thiazole-4-carboxylic acid |
|
33
|
134
|
7g1nA |
Crystal structure of human fabp4 in complex with rac-(1r,2r)-2-[[3-(3-methyl-1,2,4-oxadiazol-5-yl)-4,5,6,7-tetrahydro-1-benzothiophen-2-yl]carbamoyl]cyclohexane-1-carboxylic acid |
|
32
|
134
|
7g0sA |
Crystal structure of human fabp4 in complex with 2,3-bis(phenylmethoxy)benzoic acid |
|
31
|
134
|
7fysA |
Crystal structure of human fabp4 in complex with 7-(4-methoxyphenyl)-1,8-dithia-3-azaspiro[4.5]dec-6-ene-2,4-dione |
|
32
|
134
|
7g0qA |
Crystal structure of human fabp4 in complex with 4-[3-(4-chlorophenyl)-1,2,4-oxadiazol-5-yl]butanoic acid |
|
30
|
133
|
7fyqA |
Crystal structure of human fabp4 in complex with 2-(3,5-ditert-butyl-2-hydroxyphenyl)-3,3,3-trifluoro-2-hydroxypropanoic acid |
|
36
|
133
|
7fydA |
Crystal structure of human fabp5 in complex with 6-chloro-4-phenyl-2-propan-2-ylquinoline-3-carboxylic acid |
|
31
|
134
|
7fz8A |
Crystal structure of human fabp4 in complex with thieno[2,3-d]pyrimidine-2,4-diamine |
|
30
|
134
|
7fz3A |
Crystal structure of human fabp4 in complex with 4-(4-chlorophenoxy)benzenesulfinic acid:sodium hydride |
|
29
|
130
|
7fx2A |
Crystal structure of human fabp4 binding site mutated to that of fabp5 in complex with 2-[[6,6-difluoro-3-(4-methyl-1,3-thiazol-2-yl)-5,7-dihydro-4h-1-benzothiophen-2-yl]carbamoyl]cyclohexene-1-carboxylic acid |
|
31
|
135
|
7fwmA |
Crystal structure of human fabp4 binding site mutated to that of fabp3 in complex with 1-[(4-chloro-2-phenylphenyl)methyl]-4-hydroxypyridin-2-one |
|
35
|
133
|
7fyzA |
Crystal structure of human fabp4 in complex with 2-[2,3-bis[(2-chlorophenyl)methoxy]phenyl]-2-methoxyacetic acid |
|
32
|
130
|
7fyhA |
Crystal structure of human fabp4 binding site mutated to that of fabp5 in complex with 6-fluoro-1,3-benzothiazol-2-amine |
|
27
|
130
|
7fwfA |
Crystal structure of human fabp4 binding site mutated to that of fabp5 in complex with 5-cyclohexyl-6-(2,2,2-trifluoroethoxy)-2-(trifluoromethyl)pyridine-3-carboxylic acid |
|
28
|
130
|
7fzuA |
Crystal structure of human fabp4 binding site mutated to that of fabp5 in complex with 2-(indole-1-carbonylamino)benzoic acid |
|
31
|
130
|
7g0cA |
Crystal structure of human fabp4 binding site mutated to that of fabp5 in complex with 2-[2,3-bis[(2-chlorophenyl)methoxy]phenyl]-2-methoxyacetic acid |
|
30
|
133
|
7g09A |
Crystal structure of human fabp4 in complex with 8-(3-bromophenyl)-7,9-dioxa-1-thia-3-azaspiro[4.5]decane-2,4-dione |
|
30
|
134
|
7fwzA |
Crystal structure of human fabp4 in complex with 4-[3-(trifluoromethyl)-5,6,7,8-tetrahydro-4h-cyclohepta[c]pyrazol-1-yl]butanoic acid |
|
30
|
134
|
7fzrA |
Crystal structure of human fabp4 in complex with 4-hydroxy-6-(2-naphthalen-1-ylethyl)pyran-2-one |
|
31
|
131
|
7fzeA |
Ammonium sulfate-based apo human fabp4, primitive orthorhombic form i |
|
35
|
134
|
7fzhA |
Crystal structure of human fabp4 in complex with 4-[[3-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)-6,6-difluoro-5,7-dihydro-4h-1-benzothiophen-2-yl]carbamoyl]-3,6-dihydro-2h-pyran-5-carboxylic acid |
|
31
|
135
|
7fxpA |
Crystal structure of human fabp4 in complex with (z)-4-(4-bromo-2-chloroanilino)-4-oxobut-2-enoic acid |
|
35
|
130
|
7fxoA |
Crystal structure of apo human fabp1 monoclinic form iii |
|
26
|
130
|
7fxsA |
Crystal structure of human fabp4 binding site mutated to that of fabp5 in complex with 5-phenoxy-6-(2,2,2-trifluoroethoxy)-2-(trifluoromethyl)pyridine-3-carboxylic acid |
|
30
|
133
|
7fxqA |
Crystal structure of human fabp4 in complex with 2-(5,6,7,8,9,10-hexahydrobenzo[8]annulen-3-yl)acetic acid |
|
32
|
133
|
7fxcA |
Crystal structure of human fabp4 in complex with 6-[(3,4-dichlorophenyl)methyl]-5-methyl-1,1-dioxo-1,2,6-thiadiazin-3-one |
|
31
|
134
|
7fw6A |
Crystal structure of human fabp4 in complex with 2-[(3-chlorophenoxy)methyl]-4-phenoxycyclohexane-1-carboxylic acid |
|
33
|
133
|
7fw7A |
Crystal structure of human fabp4 in complex with 2-[(3-chloro-4-fluorophenyl)carbamoyl]cyclohexane-1-carboxylic acid |
|
31
|
134
|
7fxdA |
Crystal structure of human fabp5 in complex with 2-(indole-1-carbonylamino)benzoic acid |
|
31
|
134
|
7fxbA |
Crystal structure of human fabp4 in complex with 2-methyl-2-(2,3,4,5,6-pentachlorophenoxy)propanoic acid |
|
32
|
133
|
7fxaA |
Crystal structure of human fabp4 in complex with 6-bromo-4-hexyl-2-oxo-1,3-dihydroquinoline-4-carboxylic acid |
|
32
|
133
|
7fvzA |
Crystal structure of human fabp4 in complex with (e)-6-(5-methoxy-3,6,7-trimethyl-1,2-benzoxazol-4-yl)-4-methyl-hex-4-enoic acid |
|
29
|
132
|
7fwtA |
Crystal structure of apo mouse fabp4 |
|
29
|
134
|
7fw8A |
Crystal structure of human fabp4 binding site mutated to that of fabp3 in complex with 6-chloro-2-methyl-4-phenylquinoline-3-carboxylic acid |
|
32
|
133
|
7fw5A |
Crystal structure of human fabp4 with active site mutated to that of fabp3 in complex with palmitate |
|
29
|
134
|
7fxkA |
Crystal structure of human fabp4 in complex with 5-benzyl-4-(2,5-dimethylpyrrol-1-yl)-1,2,4-triazole-3-thiol |
